These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28725246)

  • 1. Effects of vaginal cylinder position on dose distribution in patients with endometrial carcinoma in treatment of vaginal cuff brachytherapy.
    Ozdemir Y; Dolek Y; Onal C
    J Contemp Brachytherapy; 2017 Jun; 9(3):230-235. PubMed ID: 28725246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional treatment planning for vaginal cuff brachytherapy: dosimetric effects on organs at risk according to patients position.
    Iatì G; Pontoriero A; Mondello S; Brogna A; Di Pasquale A; Ielo I; Potami A; Messina G; De Renzis C; Pergolizzi S
    Brachytherapy; 2014; 13(6):568-71. PubMed ID: 24986362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric analysis of rectal filling on rectal doses during vaginal cuff brachytherapy.
    Sabater S; Arenas M; Berenguer R; Machin-Hamalainen S; Andres I; Sevillano MM; Jimenez-Jimenez E; Martos A; Lopez-Honrubia V; Fernandez-Lopez J
    Brachytherapy; 2015; 14(4):458-63. PubMed ID: 25900391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multichannel vaginal cylinder brachytherapy-Impact of tumor thickness and location on dose to organs at risk.
    Glaser SM; Kim H; Beriwal S
    Brachytherapy; 2015; 14(6):913-8. PubMed ID: 26412618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?
    Patel S; Mehta KJ; Kuo HC; Ohri N; Patel R; Yaparpalvi R; Garg MK; Guha C; Kalnicki S
    Brachytherapy; 2016; 15(2):185-90. PubMed ID: 26796601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
    Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
    Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer.
    Guler OC; Onal C; Acibuci I
    J Contemp Brachytherapy; 2015 Jan; 6(4):371-6. PubMed ID: 25834581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body Mass Index and Doses at Organs at Risk in a Mediterranean Population Treated with Postoperative Vaginal Cuff Brachytherapy.
    Sabater S; Arenas M; Berenguer R; Andres I; Jimenez-Jimenez E; Martos A; Fernandez-Lopez J; Sevillano M; Rovirosa A
    Cancer Res Treat; 2015 Jul; 47(3):473-9. PubMed ID: 25672575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of rectal/bladder filling and applicator positioning on in vivo rectal dosimetry in vaginal cuff brachytherapy using an enhanced therapy setting.
    Bergau PFL; Schirmer MA; Leha A; Leu M; Emons G; Hess CF; Hille A
    Brachytherapy; 2020; 19(2):168-175. PubMed ID: 31883803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-cavitary brachytherapy in endometrial carcinoma: experience with cobalt-60 source.
    Rullán JAD; Miguelañez MTM; Fernández RC; Gallego MC; Sánchez MM; Vicente FG; García SS
    J Contemp Brachytherapy; 2022 Jun; 14(3):227-232. PubMed ID: 36199999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.
    Kim Y; Kim YJ; Kim JY; Lim YK; Jeong C; Jeong J; Kim M; Lim MC; Seo SS; Park SY
    Brachytherapy; 2017; 16(1):116-125. PubMed ID: 27876378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
    Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
    Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric impact of bladder filling on organs at risk with barium contrast in the small bowel for adjuvant vaginal cuff brachytherapy.
    Buzón MDCS; Bayard LG; Sanchez RR; Rodríguez LÁQ; Gil SS; Higueras CM
    J Contemp Brachytherapy; 2021 Dec; 13(6):655-662. PubMed ID: 35079252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-application displacement of brachytherapy dose received by the bladder and rectum of the patients with inoperable cervical cancer.
    Marosevic G; Ljuca D; Osmic H; Fazlic S; Arsovski O; Mileusnic D
    Radiol Oncol; 2014 Jun; 48(2):203-9. PubMed ID: 24991211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of vaginal gauze packing technique with or without balloon in high-dose-rate brachytherapy of uterine cervical cancer: A crossover randomized controlled trial.
    Dhanapalan R; Pandjatcharam J; Saravanan K; Patil NH
    J Contemp Brachytherapy; 2022 Dec; 14(6):551-559. PubMed ID: 36819474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
    Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
    Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.